Sihuan Pharmaceutical Holdings Group Ltd. (SHPHF)
USD 0.05
(0.0%)
USD 0.05
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.86 Billion | 324.69 Million | 508.64 Million | 357.11 Million | 418.87 Million | 441.35 Million |
| Cost of Revenue | 564.89 Million | 116.77 Million | 130.24 Million | 79.67 Million | 85.71 Million | 81.43 Million |
| Gross Profit | 1.29 Billion | 207.91 Million | 378.4 Million | 277.44 Million | 333.15 Million | 359.91 Million |
| Operating Expenses | 1.13 Billion | 278.22 Million | 312.65 Million | 230.09 Million | 191.49 Million | 173.6 Million |
| Selling, General and Administrative Expenses | 911.21 Million | 138.8 Million | 178.49 Million | 124.42 Million | 104.33 Million | 100.94 Million |
| Research and Development Expenses | 592.01 Million | 139.41 Million | 134.15 Million | 105.66 Million | 87.16 Million | 72.66 Million |
| Other Expenses | -369.27 Million | 15.77 Million | 24.99 Million | 27.65 Million | 30.34 Million | 31.68 Million |
| Cost and Expenses | 1.69 Billion | 395 Million | 442.89 Million | 309.76 Million | 277.21 Million | 255.04 Million |
| Operating Income | 161.69 Million | -70.31 Million | 65.75 Million | 47.34 Million | 141.65 Million | 186.31 Million |
| Interest Expense | 269.33 Million | 31.71 Million | 18.43 Million | 1.19 Million | 686.01 Thousand | 6.06 Million |
| Income Tax Expense | 96.42 Million | 29.29 Million | 39.14 Million | 31.74 Million | 42.25 Million | 50.34 Million |
| Earnings before Tax | -161.26 Million | -303.95 Million | 99.62 Million | 112.87 Million | -350.85 Million | 305.57 Million |
| Net Income | -54.01 Million | -290.21 Million | 64.36 Million | 72.83 Million | -395.47 Million | 245.07 Million |
| Earnings Per Share Basic | -0.01 | -0.03 | 0.01 | 0.01 | -0.04 | 0.03 |
| Earnings Per Share Diluted | -0.01 | -0.03 | 0.01 | 0.01 | -0.04 | 0.03 |
| Weighted Average Shares Outstanding | 9.29 Billion | 9.32 Billion | 9.43 Billion | 9.46 Billion | 9.46 Billion | 9.47 Billion |
| Weighted Average Shares Outstanding (Diluted) | 9.29 Billion | 9.32 Billion | 9.48 Billion | 9.46 Billion | 9.46 Billion | 9.47 Billion |
| Gross Margin | 0.70 | 0.64 | 0.74 | 0.78 | 0.80 | 0.82 |
| EBIT Margin | 0.18 | -0.05 | 0.22 | 0.24 | 0.46 | 0.52 |
| Profit Margin | -0.03 | -0.89 | 0.13 | 0.20 | -0.94 | 0.56 |
| EBITDA | 334.31 Million | -1.54 Billion | 922.73 Million | 1.05 Billion | -2.06 Billion | 2.32 Billion |
| Earnings Before Tax Margin | 0.09 | -0.22 | 0.13 | 0.13 | 0.34 | 0.42 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 65.33 Million | 65.76 Million | 263.21 Million | 111.32 Million | 55.11 Million | 152.31 Million |
| Cost of Revenue | 23.47 Million | 23.62 Million | 89.87 Million | 35.53 Million | 17.59 Million | 44.43 Million |
| Gross Profit | 41.86 Million | 42.13 Million | 173.33 Million | 75.78 Million | 37.52 Million | 107.87 Million |
| Operating Expenses | 34.35 Million | 34.58 Million | 200.67 Million | 106.52 Million | 41.82 Million | 103.68 Million |
| Selling, General and Administrative Expenses | 31.22 Million | 31.42 Million | - | 67.29 Million | 33.32 Million | 61.26 Million |
| Research and Development Expenses | 13.45 Million | 13.54 Million | - | 39.22 Million | 20.4 Million | 42.42 Million |
| Other Expenses | -10.31 Million | -10.38 Million | 50.94 Million | - | - | - |
| Cost and Expenses | 57.83 Million | 58.2 Million | 290.55 Million | 142.06 Million | 59.42 Million | 148.12 Million |
| Operating Income | 7.5 Million | 7.55 Million | -27.33 Million | -30.74 Million | -13.76 Million | 4.19 Million |
| Interest Expense | 18.64 Million | - | 269.33 Million | 18.78 Million | - | 19.26 Million |
| Income Tax Expense | 3.35 Million | 3.37 Million | 13.64 Million | 1.45 Million | 721.88 Thousand | 12.39 Million |
| Earnings before Tax | -1.32 Million | -1.33 Million | -15.22 Million | -16.63 Million | -8.78 Million | 1.82 Million |
| Net Income | -2.29 Million | -2.31 Million | -7.64 Million | -604.85 Thousand | -299.47 Thousand | -7.16 Million |
| Earnings Per Share Basic | -0.00 | -0.00 | - | -0.00 | - | -0.00 |
| Earnings Per Share Diluted | -0.00 | -0.00 | - | -0.00 | - | -0.00 |
| Weighted Average Shares Outstanding | 9.28 Billion | 9.28 Billion | 9.29 Billion | 9.28 Billion | 8.92 Billion | 9.31 Billion |
| Weighted Average Shares Outstanding (Diluted) | 9.28 Billion | 9.28 Billion | 9.29 Billion | 9.28 Billion | 9.28 Billion | 9.31 Billion |
| Gross Margin | 0.64 | 0.64 | 0.66 | 0.68 | 0.68 | 0.71 |
| EBIT Margin | 0.12 | 0.12 | - | -0.15 | -0.16 | 0.14 |
| Profit Margin | -0.04 | -0.04 | -0.03 | -0.01 | -0.01 | -0.05 |
| EBITDA | 7.83 Million | 7.88 Million | - | -17.19 Million | -8.81 Million | 21.35 Million |
| Earnings Before Tax Margin | 0.11 | 0.11 | -0.10 | -0.28 | -0.25 | 0.03 |
AURX
TREAY
EQUITASBNK
SCSC
IOB
LDSN